Anti-OX40L antibody, anti-OX40L / anti-TNFα bispecific antibody, and uses thereof

Abstract

1006745182 Abstract The present invention relates to a novel antibody specifically binding to OX40L and a bispecific antibody specifically binding to OX40L and TNFα and, specifically, to an antibody or a bispecific antibody specifically binding to human OX40L to effectively inhibit the binding of OX40 to an OX40 receptor; a nucleic acid encoding the antibody; an expression vector comprising the nucleic acid; a transformant comprising the expression vector; a method for preparing the antibody; a pharmaceutical composition for treating autoimmune diseases or inflammatory diseases, comprising the antibody; a composition for diagnosing autoimmune diseases or inflammatory diseases, comprising the antibody; a method for diagnosing autoimmune diseases or inflammatory diseases by using the antibody; a method for providing information on diagnosis of autoimmune diseases or inflammatory diseases by using the antibody; and a kit for providing the same. 1006745182 20 26 20 80 83 24 J ul 2 02 6 1 0 0 6 7 4 5 1 8 2 2 0 2 6 2 0 8 0 8 3 2 4 J u l 2 0 2 6

Images